Eisenberg, R., Khan, S., Stansberry, J., Tsai, D., Kolasinski, S., Rieder, E., . . . Albert, D. (2004). An open-label safety and efficacy study of an anti-CD20 antibody (rituximab, Rituxan) for anti-B-cell therapy in the treatment of systemic lupus erythematosus. BioMed Central.
Trích dẫn kiểu ChicagoEisenberg, RA, et al. An Open-label Safety and Efficacy Study of an Anti-CD20 Antibody (rituximab, Rituxan) for Anti-B-cell Therapy in the Treatment of Systemic Lupus Erythematosus. BioMed Central, 2004.
Trích dẫn MLAEisenberg, RA, et al. An Open-label Safety and Efficacy Study of an Anti-CD20 Antibody (rituximab, Rituxan) for Anti-B-cell Therapy in the Treatment of Systemic Lupus Erythematosus. BioMed Central, 2004.
Cảnh báo: Các trích dẫn này có thể không phải lúc nào cũng chính xác 100%.